InvestorsHub Logo

rusty8350

01/20/18 12:52 AM

#1997 RE: Juice555 #1996

Yeah I watch them as well, not invested. Same indication cUTI as Eravacycline but eravacycline would be the choice no doubt if they can get the oral indication worked out. Thats what brought me here in the first place and likely why ttph was $50+ back when they were less far along in the approval process. Ttph still has that potential